<p>Lumexa Imaging（纳斯达克代码：LMRI - 获取免费报告）在周一的研究报告中被 Raymond James Financial 的股票研究员从 “跑赢大盘” 评级上调至 “强力买入” 评级，MarketBeat 报道。该券商目前对该股票的目标价为 23.00 美元。Raymond James Financial 的目标价意味着该公司当前价格有 112.96% 的潜在上涨空间。</p>
<p>获取 <strong>Lumexa Imaging</strong> 的提醒：</p>
<h2>Lumexa Imaging 股票上涨 6.5%</h2>
<p>周一 LMRI 开盘价为 10.80 美元。Lumexa Imaging 的 12 个月低点为 9.97 美元，12 个月高点为 19.45 美元。</p>
<h2>Lumexa Imaging 的机构交易</h2>
<p>一家机构投资者最近在 Lumexa Imaging 股票中建立了新头寸。根据该公司在最近向证券交易委员会的披露，Assetmark Inc.在第四季度收购了 Lumexa Imaging Holdings, Inc.（纳斯达克代码：LMRI - 免费报告）的新头寸。该基金收购了 1,957 股公司股票，价值约 36,000 美元。</p>
<h2>关于 Lumexa Imaging</h2>
<p>（获取免费报告）</p>
<p>我们是美国最大的诊断影像服务提供商之一 (1)。我们的平台是集成的、可扩展的，并且在为我们的利益相关者创造价值方面有着良好的业绩记录。截至 2025 年 9 月 30 日，我们及其附属公司在美国运营着第二大 (1) 门诊影像中心网络，覆盖 13 个州的 184 个中心 (2)，并与医疗系统建立了八个合资伙伴关系。我们的中心位于具有吸引力的大都市统计区（“MSAs”）。</p>
<h2>另见</h2>
<ul>
<li>五只我们更看好的股票，胜过 Lumexa Imaging</li>
<li>你的银行账户不再安全</li>
<li>黄金市场崩溃的那一天</li>
<li>一位前 CIA 特工对即将到来的崩溃的看法</li>
<li>他刚刚准确预测了另一个黄金走势……</li>
<li>~$1.5T SpaceX IPO：首次公开募股机会</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Lumexa Imaging 吗？</h2>
<p>在考虑 Lumexa Imaging 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户在更广泛的市场注意到之前立即购买的股票……而 Lumexa Imaging 并不在名单上。</p>
<p>尽管 Lumexa Imaging 目前在分析师中获得了强力买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

LMRI

<p>Raymond James Financial 将 Lumexa Imaging (NASDAQ:LMRI) 的评级从 “跑赢大盘” 上调至 “强力买入”，目标价为 23.00 美元，意味着相较于当前价格有 112.96% 的潜在上涨空间。该股票开盘价为 10.80 美元，反映出 6.5% 的涨幅。Lumexa Imaging 在 13 个州运营着 184 家门诊影像中心，是美国最大的诊断影像服务提供商之一</p>

<p>Lumexa Imaging (NASDAQ:LMRI - Get Free Report) was upgraded by equities researchers at Raymond James Financial from an &#34;outperform&#34; rating to a &#34;strong-buy&#34; rating in a research note issued to investors on Monday, MarketBeat reports. The brokerage presently has a $23.00 price objective on the stock. Raymond James Financial's target price points to a potential upside of 112.96% from the company's current price.</p>
<div class="lb-trans"><p>Lumexa Imaging（纳斯达克代码：LMRI - 获取免费报告）在周一的研究报告中被 Raymond James Financial 的股票研究员从 “跑赢大盘” 评级上调至 “强力买入” 评级，MarketBeat 报道。该券商目前对该股票的目标价为 23.00 美元。Raymond James Financial 的目标价意味着该公司当前价格有 112.96% 的潜在上涨空间。</p>
</div><p>Get <strong>Lumexa Imaging</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Lumexa Imaging</strong> 的提醒：</p>
</div><h2>Lumexa Imaging Stock Up 6.5%</h2>
<div class="lb-trans"><h2>Lumexa Imaging 股票上涨 6.5%</h2>
</div><p>LMRI opened at $10.80 on Monday. Lumexa Imaging has a twelve month low of $9.97 and a twelve month high of $19.45.</p>
<div class="lb-trans"><p>周一 LMRI 开盘价为 10.80 美元。Lumexa Imaging 的 12 个月低点为 9.97 美元，12 个月高点为 19.45 美元。</p>
</div><h2>Institutional Trading of Lumexa Imaging</h2>
<div class="lb-trans"><h2>Lumexa Imaging 的机构交易</h2>
</div><p>An institutional investor recently bought a new position in Lumexa Imaging stock. Assetmark Inc. acquired a new position in Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 1,957 shares of the company's stock, valued at approximately $36,000.</p>
<div class="lb-trans"><p>一家机构投资者最近在 Lumexa Imaging 股票中建立了新头寸。根据该公司在最近向证券交易委员会的披露，Assetmark Inc.在第四季度收购了 Lumexa Imaging Holdings, Inc.（纳斯达克代码：LMRI - 免费报告）的新头寸。该基金收购了 1,957 股公司股票，价值约 36,000 美元。</p>
</div><h2>About Lumexa Imaging</h2>
<div class="lb-trans"><h2>关于 Lumexa Imaging</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2) across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).</p>
<div class="lb-trans"><p>我们是美国最大的诊断影像服务提供商之一 (1)。我们的平台是集成的、可扩展的，并且在为我们的利益相关者创造价值方面有着良好的业绩记录。截至 2025 年 9 月 30 日，我们及其附属公司在美国运营着第二大 (1) 门诊影像中心网络，覆盖 13 个州的 184 个中心 (2)，并与医疗系统建立了八个合资伙伴关系。我们的中心位于具有吸引力的大都市统计区（“MSAs”）。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than Lumexa Imaging</li>
<li>Your Bank Account Is No Longer Safe</li>
<li>The day the gold market broke</li>
<li>What a Former CIA Agent Knows About the Coming Collapse</li>
<li>He just nailed another gold prediction …</li>
<li>~$1.5T SpaceX IPO: Pre-IPO Opportunity</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Lumexa Imaging</li>
<li>你的银行账户不再安全</li>
<li>黄金市场崩溃的那一天</li>
<li>一位前 CIA 特工对即将到来的崩溃的看法</li>
<li>他刚刚准确预测了另一个黄金走势……</li>
<li>~$1.5T SpaceX IPO：首次公开募股机会</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Lumexa Imaging Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Lumexa Imaging 吗？</h2>
</div><p>Before you consider Lumexa Imaging, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Lumexa Imaging 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lumexa Imaging wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户在更广泛的市场注意到之前立即购买的股票……而 Lumexa Imaging 并不在名单上。</p>
</div><p>While Lumexa Imaging currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>尽管 Lumexa Imaging 目前在分析师中获得了强力买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Lumexa Imaging（纳斯达克代码：LMRI）在 Raymond James Financial 被提升至 “强力买入” 评级